Literature DB >> 3141146

Both immunoglobulin promoter and enhancer sequences are targets for suppression in myeloma-fibroblast hybrid cells.

S Junker1, V Nielsen, P Matthias, D Picard.   

Abstract

When immunoglobulin (Ig)-producing B cells are fused with fibroblastic cells, expression of Igs is suppressed by a mechanism that selectively abolishes transcription of Ig genes. The suppression is also maintained in proliferating hybrids. We have used gene transfer followed by cell fusion to study this phenomenon further. Here we report that expression of a rearranged Ig heavy chain gene, stably integrated into a myeloma genome, is completely suppressed upon fusion with fibroblasts by a mechanism that is equally active on the endogenous myeloma lambda light chain gene. To define regulatory sequences within the Ig transcriptional unit that are involved in this down-regulation, we examined the transcriptional contributions of the IgH chain gene enhancer and the kappa light chain gene promoter individually by linking them to a heterologous reporter gene. Mouse myeloma cells were stably transformed with such test constructs and subsequently fused with mouse fibroblasts. To avoid any significant loss of chromosomes, hybrid cells were isolated shortly after fusion by fluorescence-activated cell sorting, and proliferating hybrids were harvested within 2-3 weeks. On the basis of RNase protection mapping of cytoplasmic RNA, and of nuclear run-on assays we showed that both the kappa light chain promoter and the IgH chain enhancer contain regulatory information that is made redundant or is suppressed in the hybrid environment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141146      PMCID: PMC454698          DOI: 10.1002/j.1460-2075.1988.tb03175.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE.

Authors:  S KIT; D R DUBBS; L J PIEKARSKI; T C HSU
Journal:  Exp Cell Res       Date:  1963-08       Impact factor: 3.905

2.  During B-cell differentiation enhancer activity and transcription rate of immunoglobulin heavy chain genes are high before mRNA accumulation.

Authors:  T Gerster; D Picard; W Schaffner
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

3.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

4.  Transcriptional and posttranscriptional control of immunoglobulin mRNA production during B lymphocyte development.

Authors:  D E Kelley; R P Perry
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

5.  Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences.

Authors:  N F Landolfi; J D Capra; P W Tucker
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

6.  Induction of c-fos and AFP expression in a differentiating teratocarcinoma cell line.

Authors:  S A Edwards; E D Adamson
Journal:  Exp Cell Res       Date:  1986-08       Impact factor: 3.905

Review 7.  Transcriptional selectivity of viral genes in mammalian cells.

Authors:  S McKnight; R Tjian
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

8.  Synergism between immunoglobulin enhancers and promoters.

Authors:  J V Garcia; L T Bich-Thuy; J Stafford; C Queen
Journal:  Nature       Date:  1986 Jul 24-30       Impact factor: 49.962

9.  The mouse immunoglobulin heavy-chain enhancer: effect on transcription in vitro and binding of proteins present in HeLa and lymphoid B cell extracts.

Authors:  P Augereau; P Chambon
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

10.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

Authors:  M S Neuberger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  7 in total

1.  The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes.

Authors:  D G Johnson; L Carayannopoulos; J D Capra; P W Tucker; J H Hanke
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

Review 2.  Negative regulation of transcription in eukaryotes.

Authors:  A R Clark; K Docherty
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

3.  The octamer/mu E4 region of the immunoglobulin heavy-chain enhancer mediates gene repression in myeloma x T-lymphoma hybrids.

Authors:  L Shen; S Lieberman; L A Eckhardt
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

4.  Extinction of retinol-binding protein gene expression in somatic cell-hybrids: identification of the target sequences.

Authors:  R Faraonio; M Musy; V Colantuoni
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

5.  Extinction of Ig genes expression in myeloma x fibroblast somatic cell hybrids is accompanied by repression of the oct-2 gene encoding a B-cell specific transcription factor.

Authors:  Y Bergman; B Strich; H Sharir; R Ber; R Laskov
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

6.  Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator.

Authors:  Z Wang; A Goldstein; R T Zong; D Lin; E J Neufeld; R H Scheuermann; P W Tucker
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells.

Authors:  M M Müller-Immerglück; W Schaffner; P Matthias
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.